Lonza

Lonza, which is offering US$3. 55 per share or $485 million, is the white knight bidder for Patheon, which had been fighting against an earlier hostile bid by New York private equity firm JLL.

Market News 2009

Lonza Group AG ( "Lonza") and the Special Committee of Independent Directors of Patheon Inc.

THE MEDICAL NEWS Editors 2010

Lonza Group AG ( "Lonza") and the Special Committee of Independent Directors of Patheon Inc.

THE MEDICAL NEWS 2010

Lonza said the transaction, which also assumes around $170 million in Arch Chemicals' debt, was partly driven by the Swiss currency's strength and Lonza's efforts to better protect itself against currency swings.

Lonza Buys U.S. Chemicals Firm Goran Mijuk 2011

ZURICH—Making use of the strong Swiss franc as a takeover tool, chemicals maker Lonza Group AG said Monday it will buy U.S. biocides firm Arch Chemicals Inc. for $1.2 billion in cash to broaden the Switzerland-based firm's product portfolio, extend its emerging-markets footprint and improve its currency hedge.

Lonza Buys U.S. Chemicals Firm Goran Mijuk 2011

Chemicals maker Lonza will buy U.S. biocides firm Arch Chemicals for $1.2 billion to broaden its product portfolio, extend its emerging-markets footprint and improve its currency hedge.

What's News 2011

"On the downside, the deal also dilutes Lonza's biotech investment case, which has hitherto been viewed as being at the core of Lonza."

Lonza Buys U.S. Chemicals Firm Goran Mijuk 2011

The deal will be financed through the issuance of euro, Swiss franc and convertible bonds to limit dilution, Lonza said.

Lonza Buys U.S. Chemicals Firm Goran Mijuk 2011

Mr. Borgas said Lonza and Arch Chemicals had been cooperating for more than 20 years and that this working relationship had intensified over the past one-and-a-half years, making the deal a strategic fit as the U.S. company will complement Lonza's pharmaceutical-based product portfolio and extend its foothold in emerging markets, such as South Africa and Brazil.

Lonza Buys U.S. Chemicals Firm Goran Mijuk 2011

"The strong franc has certainly helped facilitate this takeover...which is the next big step in our expansion," said Lonza Chief Executive Stefan Borgas .

Lonza Buys U.S. Chemicals Firm Goran Mijuk 2011